1. Stocks
    2. /
  2. Cryosite Ltd (ASX: CTE)
    3. /

Cryosite Ltd (ASX: CTE) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Cryosite Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $38.80 million
P/E Ratio 22.91
Dividend Yield 8.78%
Shares Outstanding 48.81 million
Earnings per share 0.032
Dividend per share 0.07
Year To Date Return 30.58%
Earnings Yield 4.36%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Cryosite Ltd (ASX: CTE)
    Latest News

    a woman
    ⏸️ Investing

    5 AWESOME biotechs that pay healthy dividends

    | Claude Walker

    Are these 5 biotechs entering the BUY ZONE?

    Read more »

    a woman
    ⏸️ Investing

    How to use stock turnover to improve your investing

    | Claude Walker

    Paying too much for liquidity? Don't be a sucker for high-turnover stocks.

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    07 Sep 2023 $0.0150 0.00% Final 06 Oct 2023
    15 Sep 2022 $0.0100 0.00% Final 14 Oct 2022
    14 Mar 2017 $0.0050 0.00% Interim 31 Mar 2017
    07 Sep 2016 $0.0050 0.00% Final 04 Oct 2016
    11 Mar 2016 $0.0050 0.00% Interim 31 Mar 2016

    CTE ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Cryosite Ltd

    Cryosite Ltd is engaged in the provision of supply chain logistics, management of pharmaceutical products used in clinical trials. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services.

    CTE Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    19 Apr 2024 $0.80 $0.06 8.11% 70,411 $0.75 $0.81 $0.75
    18 Apr 2024 $0.74 $0.04 5.71% 6,026 $0.72 $0.74 $0.72
    17 Apr 2024 $0.70 $0.00 0.00% 6,500 $0.70 $0.70 $0.70
    16 Apr 2024 $0.70 $0.01 1.45% 10,417 $0.70 $0.70 $0.70
    15 Apr 2024 $0.69 $0.05 7.81% 27,070 $0.70 $0.70 $0.69
    09 Apr 2024 $0.64 $-0.04 -5.88% 3,784 $0.68 $0.70 $0.64
    08 Apr 2024 $0.68 $-0.02 -2.86% 3,053 $0.69 $0.69 $0.68
    02 Apr 2024 $0.70 $0.01 1.45% 20,000 $0.71 $0.71 $0.70
    28 Mar 2024 $0.69 $0.01 1.47% 13,756 $0.68 $0.69 $0.68

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    21 Dec 2023 Andrew Kroger Sell 500,000 $300,000
    Off-market trade.
    21 Dec 2023 Mark Kerr Buy 500,000 $300,000
    Off-market trade.
    20 Dec 2023 Andrew Kroger Sell 1,000,000 $600,000
    Off-market trade.
    20 Dec 2023 Mark Kerr Buy 1,000,000 $600,000
    Off-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Andrew John Kroger Non-Executive Director Nov 2011
    Mr Kroger had a career in stockbroking, law and general management including two years running Forsayth Group in 1990 which was Australia's ninth largest gold producer at that time. Andrew is the owner of Process Wastewater Technologies LLC, a company with its major business being in wastewater in the United States.
    Mr Mark Gregory Kerr Non-Executive ChairmanNon-Executive Director Dec 2023
    Mr Kerr has a career with public companies. He is the founding Chairman of Nido Education Ltd, an ASX listed company (ASX: NDO).
    Mr Andrew Kerr Non-Executive Director Feb 2024
    Mr Kerr is a financial services professional in both the Australian and international markets Through his roles at Bank of America Merrill Lynch and Macquarie Bank, Andrew has obtained sustainability and ESG credentials.
    Mr John Hogg Chief Executive Officer Oct 2020
    -
    Ms Dray Andrea Company Secretary Jan 2023
    -
    John Hogg Chief Executive Officer
    -
    Jane Hao Chief Financial Officer
    -
    Dray Andrea Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Mr Andrew Kroger And Related Entities 22,543,702 46.19%
    Mr Mark Gregory Kerr & Mrs Linda Marie Kerr 4,654,494 9.54%
    Mr Gary Griffith Robins & Mr Allan James Robins 4,121,184 8.44%
    Mr Alistair David Strong 2,025,000 4.15%
    DMX Capital Partners Limited 1,642,945 3.37%
    Dulhunty Management Pty Ltd 1,330,000 2.72%
    BNP PARIBAS NOMINEES PTY LTD 1,248,518 2.56%
    Bfa Super Pty Ltd 1,000,000 2.05%
    Mr John Hogg 650,000 1.33%
    Thirty Sixth Vilmar Pty Ltd 579,099 1.19%
    Ginga Pty Ltd 567,957 1.16%
    H F A Administration Pty Limited 542,000 1.11%
    Sunnyit Pty Ltd 500,000 1.02%
    Mrs Jane Susan Milliken 350,917 0.72%
    Bell Potter Nominees Ltd 350,000 0.72%
    Mr Stephen Roberts 337,707 0.69%
    Castlereagh Equity Pty Ltd 300,000 0.61%
    M N J Holdings Pty Ltd 214,931 0.44%
    Naron Nominees Pty Ltd 213,007 0.44%
    Mrs Michele Eve Robins 200,000 0.41%

    Profile

    since

    Note